US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 16.500
  • -0.310-1.84%
Close Dec 13 16:00 ET
  • 16.500
  • 0.0000.00%
Post 20:01 ET
18.70BMarket Cap-19.41P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.49%4.33B
7.40%4.16B
4.29%3.82B
6.16%15.85B
14.78%4.46B
7.09%3.85B
2.43%3.88B
0.03%3.66B
-6.01%14.93B
-5.29%3.88B
Operating revenue
13.29%4.23B
7.61%4.06B
3.67%3.7B
5.37%15.28B
9.85%4.21B
8.02%3.73B
2.50%3.77B
0.99%3.57B
-5.74%14.5B
-3.99%3.83B
Cost of revenue
9.20%2.18B
2.79%2.14B
-1.49%2.05B
3.12%8.2B
-3.41%2.04B
3.79%2B
4.52%2.08B
8.22%2.08B
-4.01%7.95B
3.07%2.11B
Gross profit
16.05%2.15B
12.69%2.02B
11.95%1.77B
9.64%7.65B
36.44%2.42B
10.90%1.85B
0.11%1.8B
-9.08%1.58B
-8.18%6.97B
-13.66%1.77B
Operating expense
6.11%1.16B
5.04%1.21B
5.12%1.13B
3.92%4.45B
-0.53%1.13B
10.25%1.1B
4.45%1.15B
1.99%1.07B
-4.72%4.28B
-7.35%1.14B
Selling and administrative expenses
9.48%924M
3.19%939M
5.23%886M
1.54%3.5B
7.77%902M
2.68%844M
0.33%910M
-4.32%842M
-2.35%3.45B
-7.82%837M
-Selling and marketing expense
8.68%626M
8.79%656M
11.36%608M
3.13%2.34B
11.11%610M
6.86%576M
1.52%603M
-6.51%546M
-6.75%2.27B
-13.00%549M
-General and administrative expense
11.19%298M
-7.82%283M
-6.08%278M
-1.53%1.16B
1.39%292M
-5.30%268M
-1.92%307M
0.00%296M
7.37%1.18B
3.97%288M
Research and development costs
-5.14%240M
12.08%269M
3.42%242M
13.72%953M
8.10%227M
44.57%253M
5.26%240M
4.00%234M
-13.34%838M
-13.93%210M
Other operating expenses
----
----
150.00%1M
----
----
----
----
96.15%-2M
----
----
Operating profit
30.50%984M
26.32%816M
26.38%642M
18.74%3.19B
102.52%1.29B
11.87%754M
-6.78%646M
-26.06%508M
-13.20%2.69B
-23.03%635M
Net non-operating interest income expense
2.86%-272M
10.07%-241M
3.85%-250M
-10.49%-1.1B
-6.30%-287M
-11.11%-280M
-27.01%-268M
-0.78%-260M
-3.01%-991M
-71.97%-270M
Non-operating interest expense
-2.86%272M
-10.07%241M
-3.85%250M
10.65%1.03B
5.74%221M
11.11%280M
27.01%268M
0.78%260M
4.38%930M
143.02%209M
Total other finance cost
----
----
----
8.20%66M
----
----
----
----
-14.08%61M
----
Other net income (expense)
-152.57%-1.03B
36.77%-822M
-64.88%-859M
43.96%-2.72B
68.42%-493M
-60.39%-409M
20.88%-1.3B
62.79%-521M
-228.31%-4.86B
-84.73%-1.56B
Gain on sale of security
----
----
----
46.15%38M
----
----
----
----
126.80%26M
----
Special income (charges)
-153.13%-1.05B
37.84%-823M
-71.29%-877M
43.47%-2.75B
68.91%-495M
-63.78%-416M
19.02%-1.32B
62.87%-512M
-256.23%-4.86B
-109.20%-1.59B
-Less：Restructuring and merger&acquisition
1.85%55M
138.64%210M
1.10%92M
61.92%659M
124.21%426M
74.19%54M
-8.33%88M
1.11%91M
190.71%407M
272.55%190M
-Less:Impairment of capital assets
1,041.67%548M
-31.52%530M
261.17%679M
-55.95%1.08B
-95.29%68M
71.43%48M
-4.44%774M
13.94%188M
319.01%2.45B
689.62%1.45B
-Less:Other special charges
43.31%450M
-82.03%83M
-54.51%106M
-49.83%1.04B
38.10%29M
61.03%314M
-36.63%462M
-79.27%233M
196.42%2.07B
-96.41%21M
-Gain on sale of business
----
----
----
-93.48%3M
----
----
----
----
-9.80%46M
----
-Gain on sale of property,plant,equipment
----
----
----
38.89%25M
----
----
----
----
157.14%18M
----
Other non- operating income (expenses)
185.71%20M
-95.83%1M
300.00%18M
46.15%-14M
-820.00%-36M
800.00%7M
400.00%24M
57.14%-9M
-36.84%-26M
-61.54%5M
Income before tax
-606.25%-324M
73.35%-246M
-71.69%-467M
80.27%-624M
142.29%507M
-61.45%64M
20.43%-923M
71.99%-272M
-580.70%-3.16B
-585.14%-1.2B
Income tax
675.00%69M
4,037.50%630M
-173.68%-52M
98.91%-7M
-72.48%41M
-111.21%-12M
98.22%-16M
-1,050.00%-19M
-404.74%-643M
720.83%149M
Earnings from equity interest net of tax
--3M
100.00%2M
---4M
-90.48%2M
0.00%1M
----
--1M
----
133.33%21M
--1M
Net income
-606.49%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
32.76%77M
-249.81%-906M
73.42%-253M
-648.03%-2.5B
-786.18%-1.35B
Net income continuous Operations
-613.16%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
31.03%76M
-248.46%-906M
73.42%-253M
-648.03%-2.5B
-792.05%-1.35B
Minority interest income
487.50%47M
17.14%-29M
-748.48%-280M
-5.66%-56M
112.50%4M
166.67%8M
-29.63%-35M
-1,200.00%-33M
-235.90%-53M
-557.14%-32M
Net income attributable to the parent company
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
-686.57%-2.45B
-726.42%-1.31B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
-686.57%-2.45B
-726.42%-1.31B
Basic earnings per share
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
-678.95%-2.2
-685.71%-1.1
Diluted earnings per share
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
-678.95%-2.2
-685.71%-1.1
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 12.49%4.33B 7.40%4.16B 4.29%3.82B 6.16%15.85B 14.78%4.46B 7.09%3.85B 2.43%3.88B 0.03%3.66B -6.01%14.93B -5.29%3.88B
Operating revenue 13.29%4.23B 7.61%4.06B 3.67%3.7B 5.37%15.28B 9.85%4.21B 8.02%3.73B 2.50%3.77B 0.99%3.57B -5.74%14.5B -3.99%3.83B
Cost of revenue 9.20%2.18B 2.79%2.14B -1.49%2.05B 3.12%8.2B -3.41%2.04B 3.79%2B 4.52%2.08B 8.22%2.08B -4.01%7.95B 3.07%2.11B
Gross profit 16.05%2.15B 12.69%2.02B 11.95%1.77B 9.64%7.65B 36.44%2.42B 10.90%1.85B 0.11%1.8B -9.08%1.58B -8.18%6.97B -13.66%1.77B
Operating expense 6.11%1.16B 5.04%1.21B 5.12%1.13B 3.92%4.45B -0.53%1.13B 10.25%1.1B 4.45%1.15B 1.99%1.07B -4.72%4.28B -7.35%1.14B
Selling and administrative expenses 9.48%924M 3.19%939M 5.23%886M 1.54%3.5B 7.77%902M 2.68%844M 0.33%910M -4.32%842M -2.35%3.45B -7.82%837M
-Selling and marketing expense 8.68%626M 8.79%656M 11.36%608M 3.13%2.34B 11.11%610M 6.86%576M 1.52%603M -6.51%546M -6.75%2.27B -13.00%549M
-General and administrative expense 11.19%298M -7.82%283M -6.08%278M -1.53%1.16B 1.39%292M -5.30%268M -1.92%307M 0.00%296M 7.37%1.18B 3.97%288M
Research and development costs -5.14%240M 12.08%269M 3.42%242M 13.72%953M 8.10%227M 44.57%253M 5.26%240M 4.00%234M -13.34%838M -13.93%210M
Other operating expenses ---- ---- 150.00%1M ---- ---- ---- ---- 96.15%-2M ---- ----
Operating profit 30.50%984M 26.32%816M 26.38%642M 18.74%3.19B 102.52%1.29B 11.87%754M -6.78%646M -26.06%508M -13.20%2.69B -23.03%635M
Net non-operating interest income expense 2.86%-272M 10.07%-241M 3.85%-250M -10.49%-1.1B -6.30%-287M -11.11%-280M -27.01%-268M -0.78%-260M -3.01%-991M -71.97%-270M
Non-operating interest expense -2.86%272M -10.07%241M -3.85%250M 10.65%1.03B 5.74%221M 11.11%280M 27.01%268M 0.78%260M 4.38%930M 143.02%209M
Total other finance cost ---- ---- ---- 8.20%66M ---- ---- ---- ---- -14.08%61M ----
Other net income (expense) -152.57%-1.03B 36.77%-822M -64.88%-859M 43.96%-2.72B 68.42%-493M -60.39%-409M 20.88%-1.3B 62.79%-521M -228.31%-4.86B -84.73%-1.56B
Gain on sale of security ---- ---- ---- 46.15%38M ---- ---- ---- ---- 126.80%26M ----
Special income (charges) -153.13%-1.05B 37.84%-823M -71.29%-877M 43.47%-2.75B 68.91%-495M -63.78%-416M 19.02%-1.32B 62.87%-512M -256.23%-4.86B -109.20%-1.59B
-Less：Restructuring and merger&acquisition 1.85%55M 138.64%210M 1.10%92M 61.92%659M 124.21%426M 74.19%54M -8.33%88M 1.11%91M 190.71%407M 272.55%190M
-Less:Impairment of capital assets 1,041.67%548M -31.52%530M 261.17%679M -55.95%1.08B -95.29%68M 71.43%48M -4.44%774M 13.94%188M 319.01%2.45B 689.62%1.45B
-Less:Other special charges 43.31%450M -82.03%83M -54.51%106M -49.83%1.04B 38.10%29M 61.03%314M -36.63%462M -79.27%233M 196.42%2.07B -96.41%21M
-Gain on sale of business ---- ---- ---- -93.48%3M ---- ---- ---- ---- -9.80%46M ----
-Gain on sale of property,plant,equipment ---- ---- ---- 38.89%25M ---- ---- ---- ---- 157.14%18M ----
Other non- operating income (expenses) 185.71%20M -95.83%1M 300.00%18M 46.15%-14M -820.00%-36M 800.00%7M 400.00%24M 57.14%-9M -36.84%-26M -61.54%5M
Income before tax -606.25%-324M 73.35%-246M -71.69%-467M 80.27%-624M 142.29%507M -61.45%64M 20.43%-923M 71.99%-272M -580.70%-3.16B -585.14%-1.2B
Income tax 675.00%69M 4,037.50%630M -173.68%-52M 98.91%-7M -72.48%41M -111.21%-12M 98.22%-16M -1,050.00%-19M -404.74%-643M 720.83%149M
Earnings from equity interest net of tax --3M 100.00%2M ---4M -90.48%2M 0.00%1M ---- --1M ---- 133.33%21M --1M
Net income -606.49%-390M 3.53%-874M -65.61%-419M 75.39%-615M 134.67%467M 32.76%77M -249.81%-906M 73.42%-253M -648.03%-2.5B -786.18%-1.35B
Net income continuous Operations -613.16%-390M 3.53%-874M -65.61%-419M 75.39%-615M 134.67%467M 31.03%76M -248.46%-906M 73.42%-253M -648.03%-2.5B -792.05%-1.35B
Minority interest income 487.50%47M 17.14%-29M -748.48%-280M -5.66%-56M 112.50%4M 166.67%8M -29.63%-35M -1,200.00%-33M -235.90%-53M -557.14%-32M
Net income attributable to the parent company -733.33%-437M 2.98%-846M 36.82%-139M 77.15%-559M 135.24%463M 23.21%69M -275.86%-872M 76.96%-220M -686.57%-2.45B -726.42%-1.31B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -733.33%-437M 2.98%-846M 36.82%-139M 77.15%-559M 135.24%463M 23.21%69M -275.86%-872M 76.96%-220M -686.57%-2.45B -726.42%-1.31B
Basic earnings per share -750.00%-0.39 3.85%-0.75 40.00%-0.12 77.27%-0.5 137.27%0.41 20.00%0.06 -271.43%-0.78 76.74%-0.2 -678.95%-2.2 -685.71%-1.1
Diluted earnings per share -750.00%-0.39 3.85%-0.75 40.00%-0.12 77.27%-0.5 137.27%0.41 20.00%0.06 -271.43%-0.78 76.74%-0.2 -678.95%-2.2 -685.71%-1.1
Dividend per share 0 0 0 0 0 0 0 0 0 0
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- -- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Broadcom
AVGO
+24.43%
Taiwan Semiconductor
TSM
+4.98%
Micron Technology
MU
+4.34%
Tesla
TSLA
+4.34%
ASML Holding
ASML
+0.77%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.04%